It has been reported that the serum concentrations of S100A8, S100A9, and IL-18 are increased in sJIA patients (3, –5), but no study has been conducted to determine whether these biomarkers can be used in the diagnosis of sJIA. This evidence concerns the gene S100A9 and systemic-onset juvenile idiopathic arthritis.